An Aiims study suggests lymph node removal after chemotherapy may improve survival in advanced ovarian cancer patients, ...

We are pleased to have the opportunity to present new data from the Phase 2 OVATION 2 Study of IMNN-001 in an oral presentation at ASCO’s Annual Meeting,” said Stacy Lindborg, Ph.D., president and ...

For a long time, scientists thought this cancer came from the ovaries. But this new research, led by Professor Alexander ...

Data shows Norway, which is similar in population size to NZ, increased its five-year survival rates for ovarian cancer from 34.1% to 46.1% in the almost two decades from 1995. In contrast, New ...

Most women with epithelial ovarian cancer are diagnosed with stage III and IV disease and require cytoreductive surgery followed by platinum-based chemotherapy Women diagnosed with and treated for ...

Ovarian cancer is a relatively manageable malignancy ... HE4 is among the most frequently upregulated genes in epithelial ovarian carcinomas based on gene expression profiles.

The study enrolled adults with platinum-resistant, FRα-expressing high-grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer who have received one to three prior systemic ...

Lynparza has been FDA-approved since 2018 for use with or without bevacizumab – sold by Roche as Avastin – as a maintenance therapy for epithelial ovarian cancer BRCA mutations who have ...

Five scientists from The University of Texas MD Anderson Cancer Center will be recognized with Scientific Achievement Awards ...

Cancer Res (2025) 85 (8_Supplement_1): 283. We previously reported that lipoprotein promoted cell proliferation of epithelial ovarian cancer (EOC) cells in vitro. Moreover, we demonstrated High-Fat ...